Principal Financial Group Inc Acadia Pharmaceuticals Inc Transaction History

Principal Financial Group Inc

$1.66 Trillion
Q3 2024

29 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Oct 31, 2024	BUY	$15.14 - $19.14 $792,427 - $1 Million	52,340 Added 67.79%	129,551 $1.99 Million
Q2 2024 Jul 29, 2024	SELL	$14.62 - $18.42 $110,892 - $139,715	-7,585 Reduced 8.94%	77,211 $1.25 Million
Q1 2024 Apr 29, 2024	SELL	$17.79 - $30.86 $203,126 - $352,359	-11,418 Reduced 11.87%	84,796 $1.57 Million
Q4 2023 Feb 07, 2024	BUY	$20.78 - $31.77 $375,577 - $574,210	18,074 Added 23.13%	96,214 $3.01 Million
Q3 2023 Nov 02, 2023	BUY	$20.84 - $33.47 $311,724 - $500,644	14,958 Added 23.67%	78,140 $1.63 Million
Q2 2023 Aug 07, 2023	SELL	$17.8 - $25.65 $63,207 - $91,083	-3,551 Reduced 5.32%	63,182 $1.51 Million
Q1 2023 May 09, 2023	SELL	$16.32 - $20.92 $134,476 - $172,380	-8,240 Reduced 10.99%	66,733 $1.26 Million
Q4 2022 Feb 09, 2023	BUY	$14.2 - $18.63 $126,025 - $165,341	8,875 Added 13.43%	74,973 $1.19 Million
Q3 2022 Nov 09, 2022	SELL	$14.11 - $18.27 $738,023 - $955,612	-52,305 Reduced 44.18%	66,098 $1.08 Million
Q2 2022 Aug 10, 2022	BUY	$13.01 - $27.22 $1.02 Million - $2.12 Million	78,054 Added 193.45%	118,403 $1.67 Million
Q1 2022 May 09, 2022	BUY	$20.94 - $27.5 $18,510 - $24,310	884 Added 2.24%	40,349 $977,000
Q4 2021 Feb 09, 2022	SELL	$16.79 - $27.09 $308,566 - $497,860	-18,378 Reduced 31.77%	39,465 $921,000
Q3 2021 Nov 09, 2021	BUY	$15.78 - $24.77 $27,757 - $43,570	1,759 Added 3.14%	57,843 $961,000
Q2 2021 Aug 10, 2021	BUY	$19.4 - $27.42 $153,124 - $216,426	7,893 Added 16.38%	56,084 $0
Q1 2021 May 10, 2021	BUY	$25.02 - $54.99 $52,817 - $116,083	2,111 Added 4.58%	48,191 $1.24 Million
Q4 2020 Feb 08, 2021	SELL	$41.04 - $56.79 $26,511 - $36,686	-646 Reduced 1.38%	46,080 $2.46 Million
Q3 2020 Nov 06, 2020	SELL	$36.42 - $57.0 $359,064 - $561,963	-9,859 Reduced 17.42%	46,726 $0
Q2 2020 Aug 05, 2020	SELL	$39.26 - $52.73 $357,226 - $479,790	-9,099 Reduced 13.85%	56,585 $2.74 Million
Q1 2020 May 12, 2020	BUY	$31.65 - $46.87 $74,852 - $110,847	2,365 Added 3.74%	65,684 $2.78 Million
Q4 2019 Feb 05, 2020	SELL	$36.21 - $51.4 $1.11 Million - $1.58 Million	-30,646 Reduced 32.61%	63,319 $2.71 Million
Q3 2019 Nov 13, 2019	BUY	$22.22 - $44.01 $186,159 - $368,715	8,378 Added 9.79%	93,965 $3.38 Million
Q2 2019 Aug 12, 2019	BUY	$23.32 - $28.12 $1.23 Million - $1.49 Million	52,869 Added 161.59%	85,587 $2.29 Million
Q1 2019 May 10, 2019	BUY	$16.17 - $27.38 $26,955 - $45,642	1,667 Added 5.37%	32,718 $879,000
Q4 2018 Feb 14, 2019	SELL	$14.32 - $22.92 $100,282 - $160,508	-7,003 Reduced 18.4%	31,051 $502,000
Q3 2018 Nov 14, 2018	BUY	$13.03 - $21.81 $65,892 - $110,293	5,057 Added 15.33%	38,054 $790,000
Q2 2018 Aug 13, 2018	SELL	$15.07 - $22.34 $23,931 - $35,475	-1,588 Reduced 4.59%	32,997 $0
Q1 2018 May 14, 2018	BUY	$22.47 - $32.33 $38,918 - $55,995	1,732 Added 5.27%	34,585 $777,000
Q4 2017 Feb 13, 2018	BUY	$26.84 - $39.14 $524,024 - $764,169	19,524 Added 146.48%	32,853 $989,000
Q3 2017 Nov 02, 2017	BUY	$29.49 - $38.37 $393,072 - $511,433	13,329	13,329 $502,000

Others Institutions Holding ACAD

# of Institutions

279

Shares Held

156M

Call Options Held

901K

Put Options Held

314K

View Full List

About ACADIA PHARMACEUTICALS INC

Ticker ACAD
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 161,843,008
Market Cap $2.7B
Description
ACADIA Pharmaceuticals Inc., a biopharmaceutical company, focuses on the development and commercialization of small molecule drugs that address unmet medical needs in central nervous system disorders. The company offers NUPLAZID (pimavanserin) for the treatment of hallucinations and delusions associated with Parkinson's disease psychosis. It's p...

More about ACAD

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Principal Financial Group Inc, based on Form 13F filings with the SEC.

News

Stay updated on Principal Financial Group Inc with notifications on news.

Account